3Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.Analysis of pooled data from five randomized controlled trials.Arch Intern Med,1994,154:1449-1457.
4Connolly S,Pogue J,Hart R,et al.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W):a randomised controlled trial.Lancet,2006,367:1903-1912.
5Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.Circulation,2006,114:e257-e354.
6Go AS,Hylek EM,Borowsky LH,et al.Warfarin use among ambulatory patients with nonvalvular atrial fibrillation:the anticoagulation and risk factors in atrial fibrillation (ATRIA)study.Ann Intern Med,1999,131:927-934.
7Hylek EM,Evans-Molina C,Shea C,et al.Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.Circulation,2007,115:2689-2696.
8Shen AY,Yao JF,Brar SS,et al.Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation.J Am Coll Cardiol,2007,50:309-315.
9Ansell J,Hirsh J,Hylek E,et al.Pharmacology and management of the vitamin K antagonists:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest,2008,133:160S-198S.
10Anderson JL,Home BD,Stevens SM,et al.Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.Circulation,2007,116:2563-2570.
